These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20020366)

  • 1. Mass spectrometry-based analysis of IGF-1 and hGH.
    Thevis M; Bredehöft M; Kohler M; Schänzer W
    Handb Exp Pharmacol; 2010; (195):201-7. PubMed ID: 20020366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone.
    Bidlingmaier M; Strasburger CJ
    Handb Exp Pharmacol; 2010; (195):187-200. PubMed ID: 20020365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry.
    Bredehöft M; Schänzer W; Thevis M
    Rapid Commun Mass Spectrom; 2008; 22(4):477-85. PubMed ID: 18236437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doping control analysis of selected peptide hormones using LC-MS(/MS).
    Thevis M; Thomas A; Schänzer W
    Forensic Sci Int; 2011 Dec; 213(1-3):35-41. PubMed ID: 21752560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of N-palmitoylated human growth hormone by in situ liquid-liquid extraction and MALDI tandem mass spectrometry.
    Sachon E; Nielsen PF; Jensen ON
    J Mass Spectrom; 2007 Jun; 42(6):724-34. PubMed ID: 17428000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric characterization of a biotechnologically produced full-length mechano growth factor (MGF) relevant for doping controls.
    Thevis M; Thomas A; Geyer H; Schänzer W
    Growth Horm IGF Res; 2014 Dec; 24(6):276-80. PubMed ID: 25466910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry.
    Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
    Anal Chem; 2006 Mar; 78(6):1897-903. PubMed ID: 16536426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Massspectrometrical analysis of recombinant human growth hormone Norditropin reveals amino acid exchange at M14_V14 rhGH.
    Hepner F; Csaszar E; Roitinger E; Pollak A; Lubec G
    Proteomics; 2006 Feb; 6(3):775-84. PubMed ID: 16372270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human pituitary growth hormone variants by mass spectrometry.
    Kohler M; Thomas A; Püschel K; Schänzer W; Thevis M
    J Proteome Res; 2009 Feb; 8(2):1071-6. PubMed ID: 19123788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes.
    Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
    Anal Chem; 2005 Jun; 77(11):3579-85. PubMed ID: 15924392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of mass spectrometry-based proteomics techniques for the detection of protein doping in sports.
    Kay RG; Creaser CS
    Expert Rev Proteomics; 2010 Apr; 7(2):185-8. PubMed ID: 20377386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls.
    Thomas A; Schänzer W; Delahaut P; Thevis M
    Methods; 2012 Feb; 56(2):230-5. PubMed ID: 21871962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration.
    Kay RG; Barton C; Velloso CP; Brown PR; Bartlett C; Blazevich AJ; Godfrey RJ; Goldspink G; Rees R; Ball GR; Cowan DA; Harridge SD; Roberts J; Teale P; Creaser CS
    Rapid Commun Mass Spectrom; 2009 Oct; 23(19):3173-82. PubMed ID: 19718777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes.
    Thomas A; Thevis M; Delahaut P; Bosseloir A; Schänzer W
    Anal Chem; 2007 Mar; 79(6):2518-24. PubMed ID: 17300174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells.
    Beck A; Bussat MC; Zorn N; Robillard V; Klinguer-Hamour C; Chenu S; Goetsch L; Corvaïa N; Van Dorsselaer A; Haeuw JF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):203-18. PubMed ID: 15833284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an absolute quantification method targeting growth hormone biomarkers using liquid chromatography coupled to isotope dilution mass spectrometry.
    Kirsch S; Widart J; Louette J; Focant JF; De Pauw E
    J Chromatogr A; 2007 Jun; 1153(1-2):300-6. PubMed ID: 17418226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new and sensitive on-line liquid chromatography/mass spectrometric approach for top-down protein analysis: the comprehensive analysis of human growth hormone in an E. coli lysate using a hybrid linear ion trap/Fourier transform ion cyclotron resonance mass spectrometer.
    Wu SL; Jardine I; Hancock WS; Karger BL
    Rapid Commun Mass Spectrom; 2004; 18(19):2201-7. PubMed ID: 15384137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing.
    Kuuranne T; Thomas A; Leinonen A; Delahaut P; Bosseloir A; Schänzer W; Thevis M
    Rapid Commun Mass Spectrom; 2008; 22(3):355-62. PubMed ID: 18181226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-I abuse in sport: current knowledge and future prospects for detection.
    Guha N; Sönksen PH; Holt RI
    Growth Horm IGF Res; 2009 Aug; 19(4):408-11. PubMed ID: 19467615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of GH abuse in sport: Past, present and future.
    Barroso O; Schamasch P; Rabin O
    Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.